Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Zacks Investment Research

06 Aug 2026, 01:37 UTC · 1h ago

GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims

3 claims · each scored for market impact

What matters in this story

1
GoodRx Holdings reported quarterly revenues of $200.41 million, beating the Zacks Consensus Estimate by 3.92%. — Revenue beats are generally positive, though the magnitude here is modest and year-over-year revenue actually declined slightly.
+0.20
2
GoodRx has failed to surpass consensus EPS estimates in each of the last four quarters. — A consistent inability to beat earnings expectations suggests a lack of positive surprises and limited growth momentum.
-0.20
3
GoodRx reported adjusted quarterly earnings of $0.08 per share, meeting the Zacks Consensus Estimate. — Meeting estimates exactly typically results in a neutral market reaction as the result was already priced in.
+0.00